Eyenovia
New York, New York, United States · Blockchain, Cryptocurrency, Finance
Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-g
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- New York, New York, United States
- Employees
- 13
- Industries
- Blockchain, Cryptocurrency, Finance
- Status
- Public (HYPD)
- Website
- eyenoviabio.com
- Company page
Recent activity at Eyenovia
- : SEC 8-K (1.02): On September 28, 2026, Hyperion DeFi, Inc. voluntarily repaid in full all outstanding obligations under the Loan and Security Agreement with Avenue Capital Management II, L.P., thus terminating the agreement. This Loan Agreement, which was initially set for up to $15.0 million in term loans, has been completely settled, resulting in the termination of all related documents and release of any liens on the company's assets. The decision to repay the loan indicates a shift in the company's financial strategy, suggesting improved liquidity or a reduced need for outside financing.
- : Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer
- : Hyperion DeFi Enters Joint Validator Operators' Agreement with Kinetiq Group and Pier Two
Employee benefit plans
Eyenovia files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Eyenovia: questions and answers
What does Eyenovia do?
Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-g
Where is Eyenovia headquartered?
Eyenovia is headquartered in New York, New York, United States.
How many employees does Eyenovia have?
Eyenovia has about 13 employees.
What is the latest news on Eyenovia?
On Sep 28, 2026, SEC 8-K (1.02): On September 28, 2026, Hyperion DeFi, Inc. voluntarily repaid in full all outstanding obligations under the Loan and Security Agreement with Avenue Capital Management II, L.P., thus terminating the agreement. This Loan Agreement, which was initially set for up to $15.0 million in ter
Is Eyenovia a public company?
Yes. Eyenovia is publicly traded under the ticker HYPD.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy